Cargando…
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
The high mortality rate together with an ever-growing number of annual cases have defined neoplastic disorders as “the real 21st-century disease”. Its dubious distinction also results from conventional therapy failure, which has made cancer an orphan disease. Therefore, innovative and alternative th...
Autores principales: | Nigro, Ersilia, Daniele, Aurora, Salzillo, Alessia, Ragone, Angela, Naviglio, Silvio, Sapio, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197554/ https://www.ncbi.nlm.nih.gov/pubmed/34070338 http://dx.doi.org/10.3390/ijms22115569 |
Ejemplares similares
-
AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells
por: Sapio, Luigi, et al.
Publicado: (2020) -
AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?
por: Sapio, Luigi, et al.
Publicado: (2022) -
Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines
por: Ragone, Angela, et al.
Publicado: (2022) -
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
por: Xiao, Wen-Ze, et al.
Publicado: (2019) -
Adiponectin receptor agonist AdipoRon improves skeletal muscle function in aged mice
por: Balasubramanian, Priya, et al.
Publicado: (2022)